{"id":"W2747918114","doi":"10.1089/dia.2017.0204","title":"Stability of Commercially Available Glucagon Formulation for Dual-Hormone Artificial Pancreas Clinical Use","year":2017,"lang":"en","type":"article","venue":"Diabetes Technology & Therapeutics","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"Diabetes Québec; Diabetes Canada; Université de Montréal; Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research; National Institutes of Health; National Institute of Diabetes and Digestive and Kidney Diseases; Novo Nordisk; Eli Lilly and Company","keywords":"Medicine; Artificial pancreas; Glucagon; Diabetes mellitus; Pancreas; Dual (grammatical number); Hormone; Intensive care medicine; Internal medicine; Endocrinology; Type 1 diabetes","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001372788,0.0002799151,0.0002615729,0.0002641424,0.0001965427,0.0005649872,0.0002601611,0.0003034151,0.002411685],"category_scores_gemma":[0.00187573,0.0001291066,0.0002672766,0.0002139455,0.0002890184,0.0003172316,0.0002615669,0.0005104413,0.0006013886],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003157429,"about_ca_system_score_gemma":0.0002965836,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001751532,"about_ca_topic_score_gemma":0.0001075113,"domain_scores_codex":[0.9991332,0.0002306374,0.00007024658,0.0001378772,0.0003701692,0.00005784909],"domain_scores_gemma":[0.9992532,0.0001757527,0.0002795465,0.00006571624,0.000171063,0.00005464687],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.002823913,0.000225278,0.00452558,0.0001966526,0.00005495901,0.0002079194,0.0001451006,0.0003627762,0.965951,0.0001357569,0.0003940059,0.02497712],"study_design_scores_gemma":[0.0001363369,0.008128506,0.01648029,0.00006157886,0.000152982,0.00152907,0.00012487,0.002474743,0.9622524,0.0001396496,0.008477873,0.00004154215],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9789851,0.006543134,0.01163986,0.0001621575,0.0001249903,0.00019793,0.0003849717,0.0001609689,0.001800885],"genre_scores_gemma":[0.9892475,0.001638463,0.007122428,0.000115312,0.00005384932,0.0002111286,0.0006204716,0.00006037593,0.0009304226],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002411685,"threshold_uncertainty_score":0.008067906,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1460163232464734,"score_gpt":0.3625763925129487,"score_spread":0.2165600692664753,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}